Organon FY 2022: revenue $6.2B, down 2%; diluted EPS $3.59

Key figures from this report

These are the numbers Organon reported for the year ended Dec 31, 2022, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

1. Revenue$6.2B−2% from $6.3B in FY 202110-K income statement, on EDGAR
2. Net income$917.0M−32% from $1.4B in FY 202110-K income statement, on EDGAR
3. Diluted EPS$3.59−32% from $5.31 in FY 202110-K income statement, on EDGAR
4. Cash and cash equivalents$706.0M−4% from $737.0M in FY 202110-K balance sheet, on EDGAR
5. Cash from operations$858.0MNo year-earlier figure tagged10-K/A cash flow statement, on EDGAR

Every year in the financial tables